Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Adicet Therapeutics

Clinical trials sponsored by Adicet Therapeutics, explained in plain language.

Adicet Bio ACET NASDAQ

Clinical-stage biotech developing engineered gamma-delta T cell therapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2

Engineered immune cells take on stubborn arthritis in early trial

Disease control Recruiting now

This early-phase study tests a new treatment called ADI-001 for adults with rheumatoid arthritis that hasn't improved with standard therapies. ADI-001 uses specially engineered immune cells from a donor to target and destroy faulty immune cells that drive inflammation. The main g…

Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:02 UTC